CytoDyn Inc.: 10-Q filed 2019-01-09
What CytoDyn Inc. reported in its quarterly report filed 2019-01-09 (fiscal Q2 2019): 28 published measures, 81 facts as tagged in accession 0001193125-19-005378.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-01-09
- Fiscal period
- fiscal Q2 2019
- Accession
- 0001193125-19-005378 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CytoDyn Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 20,390,953 | USD | |
| At 2018-05-31 | 4,898,998 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 28,454,877 | USD | |
| At 2018-05-31 | 18,056,969 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | -8,063,924 | USD | |
| At 2018-08-31 | -19,797,305 | USD | |
| At 2018-05-31 | -13,157,971 | USD | |
| At 2018-02-28 | -7,592,679 | USD | |
| At 2017-11-30 | -12,790,510 | USD | |
| At 2017-08-31 | -8,357,793 | USD | |
| At 2017-05-31 | -1,103,234 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 772,361 | USD | |
| At 2018-05-31 | 1,231,445 | USD | |
| At 2017-11-30 | 1,296,839 | USD | |
| At 2017-05-31 | 1,775,583 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | -14,305,380 | USD | 91 |
| 2018-06-01 to 2018-11-30 | -28,718,950 | USD | 183 |
| 2018-06-01 to 2018-08-31 | -14,413,569 | USD | 92 |
| 2018-03-01 to 2018-05-31 | -9,623,623 | USD | 92 |
| 2017-12-01 to 2018-02-28 | -17,950,100 | USD | 90 |
| 2017-09-01 to 2017-11-30 | -10,947,685 | USD | 91 |
| 2017-06-01 to 2017-11-30 | -22,575,959 | USD | 183 |
| 2017-06-01 to 2017-08-31 | -11,628,273 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-06-01 to 2018-11-30 | -26,192,989 | USD | 183 |
| 2017-06-01 to 2017-11-30 | -12,889,820 | USD | 183 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-06-01 to 2018-11-30 | 2,262 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-06-01 to 2018-11-30 | 25,736,167 | USD | 183 |
| 2017-06-01 to 2017-11-30 | 12,411,076 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-06-01 to 2018-11-30 | -2,262 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | -201,858,345 | USD | |
| At 2018-05-31 | -173,139,396 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | 2,826,919 | USD | 91 |
| 2018-06-01 to 2018-11-30 | 2,826,919 | USD | 183 |
| 2017-06-01 to 2018-05-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 10,127 | USD | |
| At 2018-05-31 | 11,228 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-06-01 to 2018-11-30 | 1,510,486 | USD | 183 |
| 2017-06-01 to 2017-11-30 | 529,617 | USD | 183 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | -15,687,790 | USD | 91 |
| 2018-06-01 to 2018-11-30 | -29,176,486 | USD | 183 |
| 2017-09-01 to 2017-11-30 | -10,775,051 | USD | 91 |
| 2017-06-01 to 2017-11-30 | -20,582,050 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 3,927,875 | USD | |
| At 2018-05-31 | 3,320,627 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | 1,726,585 | USD | 91 |
| 2018-06-01 to 2018-11-30 | 1,904,973 | USD | 183 |
| 2017-09-01 to 2017-11-30 | 1,002,656 | USD | 91 |
| 2017-06-01 to 2017-11-30 | 2,462,049 | USD | 183 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 23,982,761 | USD | |
| At 2018-05-31 | 16,733,237 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 18,852,414 | USD | |
| At 2018-05-31 | 15,841,859 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 16,416,962 | USD | |
| At 2018-05-31 | 1,531,154 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | 15,687,790 | USD | 91 |
| 2018-06-01 to 2018-11-30 | 29,176,486 | USD | 183 |
| 2017-09-01 to 2017-11-30 | 10,775,051 | USD | 91 |
| 2017-06-01 to 2017-11-30 | 20,582,050 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | 12,869,244 | USD | 91 |
| 2018-06-01 to 2018-11-30 | 24,337,910 | USD | 183 |
| 2017-09-01 to 2017-11-30 | 9,077,172 | USD | 91 |
| 2017-06-01 to 2017-11-30 | 17,225,348 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 290,649,949 | shares | |
| At 2018-05-31 | 216,722,779 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 193,503,678 | USD | |
| At 2018-05-31 | 159,764,611 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 5,596,974 | USD | |
| At 2018-08-31 | 5,073,758 | USD | |
| At 2018-05-31 | 0 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-11-30 | 16,452,951 | USD | |
| At 2018-05-31 | 1,567,143 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | -17,132,299 | USD | 91 |
| 2018-06-01 to 2018-11-30 | -31,545,869 | USD | 183 |
| 2017-09-01 to 2017-11-30 | -10,947,685 | USD | 91 |
| 2017-06-01 to 2017-11-30 | -22,575,959 | USD | 183 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | 2,663,745 | USD | 91 |
| 2018-06-01 to 2018-11-30 | 4,594,804 | USD | 183 |
| 2017-09-01 to 2017-11-30 | 1,608,743 | USD | 91 |
| 2017-06-01 to 2017-11-30 | 3,178,420 | USD | 183 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-09-01 to 2018-11-30 | 2,826,919 | USD | 91 |
| 2018-06-01 to 2018-11-30 | -2,826,919 | USD | 183 |
Inspect the source
- Entity
- CytoDyn Inc. / CIK 0001175680
- Captured
- 2026-09-20T07:44:48.635Z
- SEC response SHA-256
ccd180f98f5bd324896d13ce785229f8b7185dbfcf88932cc316c9c53bdaba90
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001175680.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))